NCT07293026

Brief Summary

Current research on the role of abdominal acupuncture in promoting postoperative gastrointestinal recovery remains limited, characterized by a lack of large-scale, standardized clinical trials, particularly with respect to long-term outcomes. This study, grounded in a rigorous randomized controlled trial design, investigates the clinical efficacy of abdominal acupuncture in enhancing gastrointestinal function following gynecologic laparoscopic surgery. The findings aim to provide a scientific foundation for improving postoperative quality of life, optimizing recovery pathways in gynecology, and identifying safer, simpler, and more effective therapeutic options. In addition, this work offers theoretical support and practical evidence to advance the clinical integration and broader application of traditional Chinese therapeutic approaches in modern surgical rehabilitation, underscoring its significant clinical value.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 21, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 18, 2025

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

October 2, 2025

Last Update Submit

December 15, 2025

Conditions

Keywords

abdominal acupuncturegastrointestinal functionquality of lifePostoperative Gastrointestinal DysfunctionPostoperative IleusPostoperative Complications

Outcome Measures

Primary Outcomes (1)

  • Time to first postoperative passage of flatus

    Elapsed time from the end of laparoscopic gynecologic surgery to the first documented passage of flatus; patient-reported and nurse-confirmed. Time is recorded in hours and minutes. Per protocol, rescue therapy may be used if no flatus by postoperative Day 3.

    From the end of surgery until the first documented passage of flatus; assessed through postoperative Day 5 or hospital discharge, whichever occurs first.

Secondary Outcomes (7)

  • Time to first postoperative bowel movement

    From the end of surgery until the first documented bowel movement; assessed through postoperative Day 5 or hospital discharge, whichever occurs first.

  • restoration of bowel sounds

    From the end of surgery until the first detection of normal bowel sounds; assessed every 8 hours through postoperative Day 5 or hospital discharge, whichever occurs first.

  • Incidence of postoperative gastrointestinal dysfunction

    From the day of surgery through postoperative Day 5 or hospital discharge, whichever occurs first.

  • Inflammatory markers

    Each parameter was assessed once preoperatively, on the day of surgery prior to treatment, and on postoperative Day 5.

  • Pain assessment

    Day 0 (day of surgery) and Postoperative Days 1 through 5; or until hospital discharge if earlier.

  • +2 more secondary outcomes

Other Outcomes (1)

  • Adverse Events

    From the day of surgery (Day 0) through Postoperative Day 19 (14 days after the final treatment session), including the treatment period and follow-up.

Study Arms (2)

Abdominal acupuncture treatment group

EXPERIMENTAL

In addition to standard postoperative care, patients received abdominal acupuncture. In the supine position, acupoints were localized proportionally from the umbilicus (CV8): 8 cun upward to CV16, 5 cun downward to the pubic symphysis, and 6 cun laterally. After aseptic skin preparation, disposable sterile needles were inserted perpendicularly. Primary points were needled at the Di level (1.0-1.5 cun) for visceral regulation and secondary points at the Ren level (0.5-1.0 cun) for peripheral stimulation. Gentle rotation was applied without lifting or thrusting, and deqi was not required. Needles were retained for 30 minutes with concurrent infrared warming. After withdrawal, sterile compression prevented bleeding. The first session was administered 4-6 hours postoperatively, followed by one daily on postoperative days 1-4, totaling five sessions. Clinical status was documented throughout.

Procedure: Abdominal acupunctureOther: Standard postoperative management protocol

control group

ACTIVE COMPARATOR

The standardized postoperative management protocol consists of the following components: 1. Early oral intake: patients may commence a liquid diet 6 hours after surgery, advance to a semi-liquid diet following the passage of flatus, and transition to a regular diet after bowel movement. 2. Early mobilization: patients are encouraged to turn in bed and initiate physical activity as early as 6 hours postoperatively, and to ambulate as soon as their condition permits. 3. Adequate fluid supplementation. 4. Maintenance of fluid-electrolyte and acid-base balance. 5. Prophylactic antibiotic therapy to prevent infection. 6. Early removal of urinary catheters, drainage tubes, and other indwelling devices. 7. Postoperative analgesia: implementation of a multimodal pain management strategy. 8. In critically ill patients, supplemental oxygen and continuous electrocardiographic monitoring are required.

Other: Standard postoperative management protocol

Interventions

Patients were positioned supine with the abdomen exposed. Acupoint selection and localization followed Abdominal Acupuncture Therapy standards, with proportional measurements taken from the umbilicus (CV8): 8 cun upward to CV16, 5 cun downward to the pubic symphysis, and 6 cun laterally. After hand hygiene and aseptic skin preparation, disposable sterile needles were inserted perpendicularly. Primary acupoints were needled at the Di level (1.0-1.5 cun) targeting visceral disorders, and secondary acupoints at the Ren level (0.5-1.0 cun) for peripheral regulation. Gentle rotation was employed without lifting/thrusting, and deqi induction was not required. Needles were retained for 30 minutes with concurrent infrared warming therapy. Post-treatment, needles were withdrawn with sterile compression applied to prevent bleeding. The first session was given 4-6 hours postoperatively, followed by one session daily on postoperative days 1-4, for a total of five sessions.

Also known as: acupuncture, Abdominal acupuncture treatment, Bo's Abdominal Acupuncture
Abdominal acupuncture treatment group

Multimodal perioperative care including early oral intake, early mobilization, fluid and electrolyte balance, prophylactic antibiotics, device removal, multimodal analgesia, and supportive monitoring; gastrointestinal prokinetics, enemas, and herbal medicines prohibited.

Abdominal acupuncture treatment groupcontrol group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients who underwent gynecologic laparoscopic total hysterectomy under general anesthesia;
  • Age between 18 and 65 years;
  • Surgical duration ranging from 0.5 to 4.5 hours;
  • Anesthesia duration ranging from 1 to 5 hours;
  • Willingness to receive acupuncture therapy without a history of adverse reactions such as needle syncope;
  • Provision of signed informed consent.

You may not qualify if:

  • Patients with comorbid conditions that may affect gastrointestinal function, including intestinal obstruction or space-occupying lesions of the digestive system;
  • Patients with severe systemic diseases, including hepatic or renal failure, cardiovascular or cerebrovascular disorders, infectious diseases such as HIV/AIDS, or severe psychiatric illness;
  • Individuals with a history of adverse reactions to acupuncture, including needle syncope;
  • Patients with local skin damage, rashes, or ulcers at the proposed acupoint sites;
  • Patients concurrently enrolled in other clinical studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou, Guangdong, 510120, China

Location

MeSH Terms

Conditions

Postoperative Complications

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • YI Chen, Ph.D

    Guangdong Provincial Hospital of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

October 2, 2025

First Posted

December 18, 2025

Study Start

December 21, 2023

Primary Completion

December 20, 2024

Study Completion

January 20, 2025

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Can be shared after research paper is published

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
It is not yet determined. The relevant content can be shared after the paper is published.

Locations